Cardioembolic stroke

References

• Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986: 43(1): 71–84
   PubMedGoogle Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham study. Arch Intern Med 1987: 147(9): 1561–4
   PubMed Web of Science ®Google Scholar
• Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989: 46(7): 727–43 [erratum, Arch Neurol 1989: 46(10): 1079]
   PubMedGoogle Scholar
• Left ventricular thrombosis and stroke following myocardial infarction. (Editorial) Lancet 1990: 335(8692): 759–60
   Google Scholar
• Turpie AG. Anticoagulant therapy after acute myocardial infarction. Am J Cardiol 1990: 65(6): 20–3C
   Web of Science ®Google Scholar
• Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990: 323(3): 147–52
   PubMed Web of Science ®Google Scholar
• Hennekens CH, Buring JE, Sandercock P, et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989: 80(4): 749–56
   PubMed Web of Science ®Google Scholar
• Haugland JM, Asinger KW, Mikell FL, et al. Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation 1984: 70(4): 588–98
   PubMed Web of Science ®Google Scholar
• Kyrle PA, Korninger C, Gössinger H, et al. Prevention of arterial and pulmonary embolism by oral anticoagulants in patients with dilated cardiomyopathy. Thromb Haemost 1985: 54(2): 521–3
   PubMed Web of Science ®Google Scholar
• Wilson WR, Danielson GK, Giuliani ER, et al. Prosthetic valve endocarditis. Mayo Clin Proc 1982: 57(3): 155–61
   PubMed Web of Science ®Google Scholar
• Levine HJ, Pauker SG, Salzman EW. Antithrombotic therapy in valvular heart disease. Chest 1989: 95(2 Suppl): 98–106S
   PubMed Web of Science ®Google Scholar
• Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 1989: 95(2 Suppl): 107–17S
   Web of Science ®Google Scholar
• Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982: 306(17): 1018–22
   PubMed Web of Science ®Google Scholar
• Phillips SJ, Whisnant JP, O'Fallon WM, et al. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990: 65(3): 344–59
   PubMed Web of Science ®Google Scholar
• Hinton RC, Kistler JP, Fallon JT, et al. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977: 40(4): 509–13
   PubMed Web of Science ®Google Scholar
• Sherman DG, Goldman L, Whiting RB, et al. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984: 41(7): 708–10
   PubMedGoogle Scholar
• Dennis M, Bamford J, Sandercock P, et al. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990: 21(6): 848–53
   PubMed Web of Science ®Google Scholar
• Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978: 28(10): 973–7
   PubMed Web of Science ®Google Scholar
• Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet 1989: 1(8631): 175–9
   PubMed Web of Science ®Google Scholar
• Preliminary report of the Stroke Prevention in Atrial Fibrillation Studv. N Engl J Med 1990: 322(12): 863–8
   PubMed Web of Science ®Google Scholar
• Meissner I, Wiebers DO, Whisnant JP, et al. The natural history of asymptomatic carotid artery occlusive lesions. JAMA 1987: 258(19): 2704–7
   PubMed Web of Science ®Google Scholar
• Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 1987: 317(11): 669–74
   PubMed Web of Science ®Google Scholar
• Davidson E, Rotenberg Z, Weinberger I, et al. Diagnosis and characteristics of lone atrial fibrillation. Chest 1989: 95(5): 1048–50
   PubMed Web of Science ®Google Scholar
• Wolf PA, Kannel WB, McGee DL, et al. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 1983: 14(5): 664–7
   PubMed Web of Science ®Google Scholar
• The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of clinical thromboembolism in atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. Ann Intern Med (in press)
   Google Scholar
• Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 1986: 17(4): 622–5
   PubMed Web of Science ®Google Scholar
• Caplan LR, D'Cruz I, Hier DB, et al. Atrial size, atrial fibrillation, and stroke. Ann Neurol 1986: 19(2): 158–61
   PubMed Web of Science ®Google Scholar
• Cabin HS, Clubb KS, Hall C, et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990: 65(16): 1112–6
   PubMed Web of Science ®Google Scholar
• Petersen P, Rastrup J, Helweg-Laisen S, et al. Risk factors for thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Arch Intern Med 1990: 150(4): 819–21
   PubMedGoogle Scholar
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990: 323(22): 1505–11
   PubMed Web of Science ®Google Scholar
• Walker MD. Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis. (Letter) Lancet 1989: 1(8633): 325–6
   PubMed Web of Science ®Google Scholar
• Petersen P. Thromboembolic complications in atrial fibrillation. Stroke 1990: 21(1): 4–13
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991: 84(2): 527–39
   PubMed Web of Science ®Google Scholar
• Connolly SJ. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. Circulation 1990: 82(4 Suppl III): III108
   Google Scholar
• WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke—1989: recommendations on stroke prevention, diagnosis, and therapy. Stroke 1989: 20(10): 1407–31
   PubMed Web of Science ®Google Scholar